Lynk Pharmaceuticals Co., Ltd
Lynk Pharmaceuticals Co., Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA) | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Phase 3 | 2026-01-14 | NCT06276998 | |
| A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis | Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Recruiting | Phase 3 | 2025-11-20 | NCT07237568 |